Darcy G. Mott Sells 9,500 Shares of HealthEquity, Inc. (HQY) Stock
HealthEquity, Inc. (NASDAQ:HQY) VP Darcy G. Mott sold 9,500 shares of the business’s stock in a transaction that occurred on Monday, August 21st. The stock was sold at an average price of $42.00, for a total value of $399,000.00. Following the sale, the vice president now owns 84,500 shares of the company’s stock, valued at approximately $3,549,000. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.
HealthEquity, Inc. (HQY) opened at 40.88 on Friday. HealthEquity, Inc. has a 52-week low of $30.34 and a 52-week high of $54.95. The firm has a market cap of $2.45 billion, a price-to-earnings ratio of 76.84 and a beta of 1.73. The firm’s 50-day moving average price is $46.96 and its 200 day moving average price is $45.88.
HealthEquity (NASDAQ:HQY) last announced its earnings results on Tuesday, June 6th. The company reported $0.19 EPS for the quarter, topping the consensus estimate of $0.16 by $0.03. The business had revenue of $55.40 million for the quarter, compared to the consensus estimate of $54.77 million. HealthEquity had a return on equity of 11.61% and a net margin of 17.04%. HealthEquity’s revenue was up 25.9% compared to the same quarter last year. During the same period in the previous year, the business earned $0.15 EPS. On average, equities research analysts forecast that HealthEquity, Inc. will post $0.58 EPS for the current year.
TRADEMARK VIOLATION NOTICE: “Darcy G. Mott Sells 9,500 Shares of HealthEquity, Inc. (HQY) Stock” was originally reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this article on another publication, it was illegally copied and reposted in violation of U.S. and international trademark & copyright laws. The legal version of this article can be accessed at https://www.thecerbatgem.com/2017/08/26/darcy-g-mott-sells-9500-shares-of-healthequity-inc-hqy-stock.html.
HQY has been the subject of several recent analyst reports. BidaskClub cut HealthEquity from a “buy” rating to a “hold” rating in a research note on Monday, July 24th. Zacks Investment Research upgraded HealthEquity from a “hold” rating to a “buy” rating and set a $54.00 target price for the company in a research note on Wednesday, July 12th. TheStreet upgraded HealthEquity from a “c” rating to a “b” rating in a research note on Monday, July 31st. Oppenheimer Holdings, Inc. restated an “outperform” rating and set a $61.00 target price (up previously from $57.00) on shares of HealthEquity in a research note on Monday, June 12th. Finally, Chardan Capital boosted their target price on HealthEquity from $53.00 to $57.00 and gave the stock a “buy” rating in a research note on Wednesday, June 7th. One analyst has rated the stock with a sell rating, two have issued a hold rating and eleven have issued a buy rating to the company. HealthEquity presently has a consensus rating of “Buy” and a consensus price target of $50.22.
Hedge funds and other institutional investors have recently made changes to their positions in the company. Wasatch Advisors Inc. increased its position in shares of HealthEquity by 2.2% in the second quarter. Wasatch Advisors Inc. now owns 2,442,180 shares of the company’s stock valued at $121,694,000 after buying an additional 52,885 shares during the last quarter. Public Employees Retirement System of Ohio increased its position in shares of HealthEquity by 5.7% in the second quarter. Public Employees Retirement System of Ohio now owns 113,534 shares of the company’s stock valued at $5,657,000 after buying an additional 6,095 shares during the last quarter. Amussen Hunsaker & Associates LLC acquired a new position in shares of HealthEquity during the second quarter valued at approximately $11,598,000. 1st Global Advisors Inc. acquired a new position in shares of HealthEquity during the second quarter valued at approximately $213,000. Finally, Piedmont Investment Advisors LLC acquired a new position in shares of HealthEquity during the second quarter valued at approximately $478,000. 90.54% of the stock is currently owned by institutional investors and hedge funds.
HealthEquity Company Profile
HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.
Receive News & Stock Ratings for HealthEquity Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity Inc. and related stocks with our FREE daily email newsletter.